Fact CheckerSign in

NCT04330456Recruiting

Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy

Source: ClinicalTrials.gov · Last updated 1 Apr 2020 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Combined treatment of soft tissue sarcoma includes 3 steps: 1. step - preoperative stereotactic radiation therapy in hypofractionation mode 2. step - operation 3. step - postoperative conformal radiation therapy in normofractionation mode

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
26 Mar 2020
Start date
1 Feb 2020
Primary completion date
1 Jul 2022
Lead sponsor
N.N. Petrov National Medical Research Center of Oncology
Diseases
Sarcoma
NCT number
NCT04330456

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Feb 2020 to the primary completion date, 1 Jul 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previous radiation treatment
  • tumor topography and volume that don't allow to perform stereotactic and conformal radiation therapy.

Other illness

  • acute infection
  • conditions that can affect the outcome of treatment (immunodeficiency, tuberculosis, etc.)

Other

  • pregnancy, lactation
  • recurrent tumor
  • refuse to sign informed consent

Who the study is looking for

  • morphologically verified diagnosis of soft tissue sarcoma
  • first diagnosed tumor process
  • ability to perform radical surgery
  • signed informed consent
  • indications for stereotactic and conformal radiation therapy
  • no contraindications for radiation and surgical treatment

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Research Center of Oncology named after N.N.Petrov
Coordinator of this site? Confirm its status
Saint PetersburgRussiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.